Insulet Corporation NASDAQ:PODD

Insulet stock price today

$327.75
+62.62
+23.62%
Financial Health
0
1
2
3
4
5
6
7
8
9

Insulet stock price monthly change

+31.26%
month

Insulet stock price quarterly change

+31.26%
quarter

Insulet stock price yearly change

+19.74%
year

Insulet key metrics

Market Cap
18.28B
Enterprise value
22.51B
P/E
5233.33
EV/Sales
17.24
EV/EBITDA
225.78
Price/Sales
16.68
Price/Book
45.72
PEG ratio
-73.09
EPS
3.35
Revenue
1.78B
EBITDA
192.3M
Income
234M
Revenue Q/Q
23.34%
Revenue Y/Y
30.16%
Profit margin
0.35%
Oper. margin
2.88%
Gross margin
61.72%
EBIT margin
2.88%
EBITDA margin
10.8%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Insulet stock price history

Insulet stock forecast

Insulet financial statements

Average Price Target
Last Year

$261

Potential downside: -20.36%

Based on estimate of 6 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Insulet Corporation (NASDAQ:PODD): Profit margin
Jun 2023 396.5M 27.3M 6.89%
Sep 2023 432.7M 51.9M 11.99%
Dec 2023 509.8M 103.3M 20.26%
Mar 2024 441.7M 51.5M 11.66%
Insulet Corporation (NASDAQ:PODD): Earnings per share (EPS)
2024-02-22 0.66 1.4
Insulet Corporation (NASDAQ:PODD): Debt to assets
Jun 2023 2385800000 1.83B 76.78%
Sep 2023 2467700000 1.86B 75.38%
Dec 2023 2588200000 1.85B 71.69%
Mar 2024 2624000000 1.83B 69.87%
Insulet Corporation (NASDAQ:PODD): Cash Flow
Jun 2023 44M -23.1M 3.2M
Sep 2023 56M -22.6M -6.9M
Dec 2023 44.9M -31.6M 2.2M
Mar 2024 87.6M -24M -14.1M

Insulet alternative data

Insulet Corporation (NASDAQ:PODD): Employee count
Aug 2023 2,600
Sep 2023 2,600
Oct 2023 2,600
Nov 2023 2,600
Dec 2023 2,600
Jan 2024 2,600
Feb 2024 2,600
Mar 2024 3,000
Apr 2024 3,000
May 2024 3,000
Jun 2024 3,000
Jul 2024 3,000

Insulet other data

100.00% 0.00%
of PODD is owned by hedge funds
70.59M +537.58K
shares is hold by hedge funds

Insulet Corporation (NASDAQ:PODD): Insider trades (number of shares)
Period Buy Sel
Feb 2024 0 11609
May 2024 0 3300
Jun 2024 0 10991
Aug 2024 100 3211
Sep 2024 0 15517
Nov 2024 0 508
Dec 2024 0 5277
Transaction Date Insider Security Shares Price per share Total value Source
Sale
BENJAMIN ERIC officer: EVP, CPXPO
Common Stock 4,362 $267.6 $1,167,271
Sale
BUDDEN LAUREN officer: Group VP, CAO and Cont..
Common Stock 915 $275.62 $252,192
Sale
BORIO LUCIANA director
Common Stock 508 $274.8 $139,598
Option
HOPFIELD JESSICA director
Common Stock 7,628 $29.87 $227,848
Sale
HOPFIELD JESSICA director
Common Stock 7,628 $225.26 $1,718,283
Option
HOPFIELD JESSICA director
Stock Option (Right to Buy) 7,628 $29.87 $227,848
Sale
SCANNELL TIMOTHY J director Common Stock 5,000 $225.84 $1,129,200
Sale
FIELD MARK N officer: SVP & Chief Technology..
Common Stock 1,383 $220.87 $305,463
Sale
BUDDEN LAUREN officer: Group VP, CAO and Cont..
Common Stock 1,506 $221.41 $333,443
Sale
SINGH PREM officer: SVP, Global Operations
Common Stock 1,824 $202.27 $368,940
Patent
Grant
Filling date: 1 Dec 2021 Issue date: 13 Sep 2022
Grant
Filling date: 29 Jul 2019 Issue date: 13 Sep 2022
Application
Filling date: 2 Mar 2022 Issue date: 8 Sep 2022
Application
Filling date: 10 Feb 2022 Issue date: 1 Sep 2022
Application
Filling date: 10 Feb 2022 Issue date: 1 Sep 2022
Application
Filling date: 9 Feb 2022 Issue date: 1 Sep 2022
Application
Filling date: 4 Feb 2022 Issue date: 11 Aug 2022
Application
Filling date: 24 Jan 2022 Issue date: 4 Aug 2022
Application
Filling date: 24 Jan 2022 Issue date: 4 Aug 2022
Application
Filling date: 19 Jan 2022 Issue date: 4 Aug 2022
Friday, 27 December 2024
fxempire.com
Friday, 13 December 2024
zacks.com
Thursday, 12 December 2024
zacks.com
Monday, 9 December 2024
zacks.com
Thursday, 5 December 2024
reuters.com
Wednesday, 4 December 2024
businesswire.com
Friday, 29 November 2024
zacks.com
Friday, 22 November 2024
zacks.com
Wednesday, 20 November 2024
seekingalpha.com
businesswire.com
Friday, 15 November 2024
businesswire.com
Tuesday, 12 November 2024
zacks.com
zacks.com
zacks.com
Monday, 11 November 2024
youtube.com
forbes.com
Thursday, 7 November 2024
seekingalpha.com
zacks.com
zacks.com
reuters.com
Monday, 4 November 2024
zacks.com
zacks.com
Friday, 1 November 2024
businesswire.com
Thursday, 31 October 2024
zacks.com
Tuesday, 29 October 2024
businesswire.com
Monday, 28 October 2024
globenewswire.com
Wednesday, 23 October 2024
zacks.com
Tuesday, 22 October 2024
zacks.com
Tuesday, 25 June 2024
zacks.com
Monday, 24 June 2024
zacks.com
  • What's the price of Insulet stock today?

    One share of Insulet stock can currently be purchased for approximately $327.75.

  • When is Insulet's next earnings date?

    Unfortunately, Insulet's (PODD) next earnings date is currently unknown.

  • Does Insulet pay dividends?

    No, Insulet does not pay dividends.

  • How much money does Insulet make?

    Insulet has a market capitalization of 18.28B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 30.02% to 1.7B US dollars. Insulet earned 206.3M US dollars in net income (profit) last year or $1.4 on an earnings per share basis.

  • What is Insulet's stock symbol?

    Insulet Corporation is traded on the NASDAQ under the ticker symbol "PODD".

  • What is Insulet's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Insulet?

    Shares of Insulet can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Insulet's key executives?

    Insulet's management team includes the following people:

    • Ms. Shacey Petrovic Pres, Chief Executive Officer & Director(age: 51, pay: $1,800,000)
    • Mr. Charles Alpuche Executive Vice President & Chief Operating Officer(age: 65, pay: $1,050,000)
    • Mr. Wayde D. McMillan Executive Vice President,Chief Financial Officer & Treasurer(age: 55, pay: $969,460)
    • Mr. Bret Christensen Executive Vice President & Chief Commercial Officer(age: 54, pay: $918,470)
    • Mr. Dan Manea Senior Vice President & Chief HR Officer(age: 58, pay: $841,640)
  • How many employees does Insulet have?

    As Jul 2024, Insulet employs 3,000 workers.

  • When Insulet went public?

    Insulet Corporation is publicly traded company for more then 18 years since IPO on 15 May 2007.

  • What is Insulet's official website?

    The official website for Insulet is insulet.com.

  • Where are Insulet's headquarters?

    Insulet is headquartered at 100 Nagog Park, Acton, MA.

  • How can i contact Insulet?

    Insulet's mailing address is 100 Nagog Park, Acton, MA and company can be reached via phone at 978 600 7000.

  • What is Insulet stock forecast & price target?

    Based on 6 Wall Street analysts` predicted price targets for Insulet in the last 12 months, the avarage price target is $261. The average price target represents a -20.36% change from the last price of $327.75.

Insulet company profile:

Insulet Corporation

insulet.com
Exchange:

NASDAQ

Full time employees:

3,000

Industry:

Medical - Devices

Sector:

Healthcare

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

100 Nagog Park
Acton, MA 01720

CIK: 0001145197
ISIN: US45784P1012
CUSIP: 45784P101